Franz Skincare

Founded in 2013, BioSensor Laboratories is a pioneered biotechnology corporation that manufactures skincare products with its patented non-invasive transdermal drug delivery system (TDDS). Through multi-disciplinary collaboration with scientists at Seoul National University and The Samsung Hospital, and an initial investment of $10 million in R&D, BSL invented the revolutionary TDDS trademarked as Tissue X Technology. Tissue X enables active ingredients to deeply penetrate from the outer skin barrier through the deepest layer of skin without applying any additional tool such as needles and skincare devices. Yet, the clinical-results are proven to be superior than most conventional procedures done by physicians or practitioners.